Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pharmaceutical supply chain headed for $5.3B valuation
Yahoo Finance
Monday, March 24, 2025 - 11:00am
tags:
pharma industry, supply chain
Lilly, Novo expand DTC reach of obesity meds after compound win
Pharma Voice
Monday, March 24, 2025 - 10:58am
tags:
Eli Lilly, Novo Nordisk, obesity, DTC, Mounjaro, Wegovy
Phase 3 readout puts Opthea at risk of insolvency
Pharmaphorum
Monday, March 24, 2025 - 10:57am
tags:
Opthea, clinical trials, wet age-related macular degeneration, sozinibercept
MIT team develops 'years-long' drug delivery tech
Pharmaphorum
Monday, March 24, 2025 - 10:56am
tags:
MIT, drug delivery
Chimerix engaged with 7 other biopharmas before choosing Jazz’s $935M deal—here’s why it won
Fierce Biotech
Sunday, March 23, 2025 - 11:45pm
tags:
Jazz Pharma, Chimerix, M&A
FDA rejects Hengrui, Elevar's PD-1 cancer drug combination—again
Fierce Pharma
Sunday, March 23, 2025 - 11:43pm
tags:
Jiangsu Hengrui, Elevar Therapeutics, camrelizumab, FDA, cancer
Trump Allies Aim to Slash Drug Prices. The Pharma Industry Is in a Bind.
Barron's
Sunday, March 23, 2025 - 11:41pm
tags:
Donald Trump, drug pricing
Gene therapy loses luster as investors eye quicker returns from weight-loss drugs
Yahoo/Reuters
Friday, March 21, 2025 - 11:42am
tags:
gene therapy, rare disease, cancer, obesity, weight loss, drug development
MacroGenics pulls plug on vobra duo ADC after seeing phase 2 prostate cancer data
Fierce Biotech
Friday, March 21, 2025 - 11:39am
tags:
Macrogenics, vobra duo, clinical trials
Potential impacts of the US withdrawal from the WHO on clinical trials globally
Clinical Trials Arena
Friday, March 21, 2025 - 11:38am
tags:
clinical trials, WHO, Public Health
Eisai's abandoned Enhertu challenger set to live on at BlissBio
Fierce Biotech
Friday, March 21, 2025 - 11:34am
tags:
Eisai, BB-1701, Bliss Bio, liquid biopsy
AstraZeneca details $2.5B investment in China's political center, funding R&D center, biotech pacts
Fierce Biotech
Friday, March 21, 2025 - 11:29am
tags:
AstraZeneca, R&D, China
J&J boosts investments in U.S. to more than $55 billion amid looming tariff threats
CNBC
Friday, March 21, 2025 - 11:27am
tags:
JNJ, drug manufacturing, tariffs
FTC commissioner firings spark legal uncertainty in PBM insulin case
Fierce Healthcare
Friday, March 21, 2025 - 11:26am
tags:
FTC, PBMs, legal
Optum Rx’s new payment model favors brand names over generics
Beckers Hospital Review
Friday, March 21, 2025 - 11:25am
tags:
Optum Rx, PBMs, generics, branded pharma
Hoop dreams: Women’s basketball drives slam dunk results for pharma brands
Medical Marketing and Media
Friday, March 21, 2025 - 11:22am
tags:
basketball, pharma marketing
How pharma could feel the pain of a recession
Pharma Voice
Friday, March 21, 2025 - 11:20am
tags:
pharma industry, economics, recession
Novartis' Fabhalta is first FDA-approved therapy for rare disease C3G
Pharmaphorum
Friday, March 21, 2025 - 11:19am
tags:
Novartis, FDA, Fabhalta, C3 glomerulopathy
Alnylam drug gets long-awaited FDA approval in deadly heart disease
BioPharma Dive
Thursday, March 20, 2025 - 10:05pm
tags:
Alnylam, Amvuttra, Pfizer, Bridge Bio, FDA, ATTR-CM
J&J advances Stelara succession scheme with key FDA nod for Tremfya in Crohn's disease
Fierce Pharma
Thursday, March 20, 2025 - 10:03pm
tags:
JNJ, Tremfya, FDA, Crohn's Disease

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.